US Approves $375 Million Deal for Experimental Coronavirus Antibody Treatment
One day after U.S. regulators canceled a trial for Eli Lilly’s experimental antibody treatment for being “unlikely to help” severe coronavirus patients, U.S. officials approved a $375 million deal for 300,000 doses of the same drug.